The federal government is preparing to help Regeneron Pharmaceuticals Inc. manufacture “tens or hundreds of thousands of doses” of the Covid-19 antibody cocktail give to President Donald Trump, HHS Secretary Alex Azar said Thursday.
The experimental therapy is one of several monoclonal antibody treatments in testing that may help treat patients with Covid-19. Regeneron said Wednesday that it has asked the Food and Drug Administration to authorize the treatment.
Trump credited the experimental treatment with his apparent recovery from the coronavirus, and announced Wednesday his intention to provide it free to Americans.
Azar also said the U.S. manufacturing facilities are ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.